Different neuromodulators usually activate distinct receptors but can have overlapping 11 targets. Consequently, circuit output depends on neuromodulator interactions at shared 12 targets, a poorly understood process. We explored quantitative rules of co-modulation of two 13 principal targets: voltage-gated and synaptic ionic currents. In the stomatogastric ganglion of 14 the crab Cancer borealis, the neuropeptides proctolin and CCAP modulate synapses of the 15 pyloric circuit, and activate a voltage-gated current (IMI) in multiple neurons. We examined the 16 validity of a simple dose-dependent quantitative rule that co-modulation by proctolin and CCAP 17 is predicted by the linear sum of the individual effects of each modulator, up to saturation. We 18 found that this rule is valid for co-modulation of synapses, but not for the activation of IMI, 19
Introduction 23
All nervous systems adapt to changes in the environment and the internal state of the 24 animal. In different contexts, awake or asleep, fed or hungry, light or dark, neuronal circuits 25 produce different output (Xia and Mills, 2004; Inagaki et al., 2014; Wester and McBain, 2014; 26 Burke et al., 2015; Filosa et al., 2016) . This context-dependent output is actively shaped by 27 various neuromodulators through changes in neuronal and synaptic properties (reviewed in 28 Brezina, 2010; Bargmann, 2012; Marder, 2012; Nadim and Bucher, 2014) . The large number of 29 neuromodulators identified within species clearly indicates that, at any time, every neuronal 30 circuit is co-modulated by a number of these substances (Marder and Bucher, 2007 Garcia et al., 2015) . 46
Neuromodulator targets fall into two categories: ionic currents that shape neuronal 47 excitability, and synapses, which determine circuit organization. In a single neuron, a single 48 neuromodulator can have multiple subcellular targets (divergence) and multiple 49 neuromodulators can have overlapping targets (convergence) (reviewed in Nadim and Bucher, 50 2014). Such patterns of divergence and convergence can result in complex co-modulatory 51 effects on neuron and synapse function, and consequently circuit output. 52
To understand how co-modulation shapes circuit output, it is important to characterize 53 how co-modulation occurs at shared targets. Here we focus on convergent co-modulation of 54 synapses and voltage-gated currents by exploring 1) if the combined actions of 55 neuromodulators on a shared target can be predicted quantitatively from their individual 56 actions, and 2) if co-modulation of synaptic and voltage-gated ionic currents in a neuron follows 57 the same rule. For neuromodulators with converging signaling pathways, the most 58 parsimonious prediction would be that their effects at a shared target simply add up linearly to 59 produce a combined effect, up to the saturation level. It should be noted, however, that such 60 linear addition does not exclude the possibility that each separate modulator effect might have 61 a distinct dose-dependence that is inherently nonlinear. In addition, the dynamics and 62 physiological effects of modulating a target can be complex and nonlinear. 63
In this study, we used the pyloric circuit of the crab stomatogastric ganglion (STG) to 64 examine whether the dose-dependent actions of two peptide neuromodulators on their targets 65 can be predicted by the linear summation of their individual actions, up to saturation. Several 66 peptides activate IMI, a voltage-gated ionic current (Golowasch and Marder, 1992 ; Swensen and 67 Marder, 2000) in STG neurons, likely through converging signaling pathways from different 68 receptors (Garcia et al., 2015; Gray et al., 2017) . Some also modulate pyloric synapses 69 (Thirumalai et al., 2006; Zhao et al., 2011; Garcia et al., 2015) . We measured the influence of 70 two peptide neuromodulators on synaptic currents and on IMI. Because the influence of the 71 peptides on these components can be assayed simultaneously, they provide a good test for 72
understanding the rules of co-modulation of different aspects of neuronal processing. We 73 found that co-modulation of synaptic transmission and the voltage-gated current follows 74 distinct rules-a mechanism likely to be generalizable. The machinery underlying 75 neuromodulation is evolutionarily well conserved and most receptors have homologs across 76 invertebrate and vertebrate systems (Mirabeau and Joly, 2013 ; Lovett-Barron et al., 2017), and 77 many neuromodulators share G-protein mediated signaling pathways (Doi and Ramirez, 2008) . 78
Thus, such distinct rules for co-modulation of different components are likely to be used in 79 other neuronal circuits and by other neuromodulators. 80
Results

81
We explored the modulatory effects of the two neuropeptides CCAP and Proc on IMI in 82 the lateral pyloric (LP), and on the reciprocal synapses between LP and the pyloric dilator (PD) 83 and neurons. The influence of these peptides on pyloric neurons and synapses can be assayed 84 simultaneously, while all other neuromodulatory inputs are removed. 85
We began by quantifying the individual modulatory effects of CCAP and Proc on both 86 synapses and IMI in the LP neuron across a range of concentrations, ranging from subthreshold 87 to saturation. These dose-dependent quantifications allowed us to build predictors of the 88 modulatory effect of each individual modulator at any concentration. 89
We then characterized the effect of co-application of both peptides in two stages. First, 90
we examined if co-modulation is history dependent by co-applying the peptides following 91 exposure to either Proc or CCAP, as interactions between neuromodulators can depend the 92 order of application and produce priming or gating ( experiments. In each experiment, we measured the effect of the peptide on both the LP to PD 99 and the PD to LP synapses. Hence, we will discuss four different synapse-peptide cases: LP to 100 PD-CCAP, LP to PD-Proc, PD to LP-CCAP and PD to LP-Proc. 101
In each synapse-peptide case, we measured the postsynaptic current in control and in 102 increasing concentrations of the peptide with simultaneous two-electrode voltage clamp 103 recordings of both neurons ( Figure 1A ). In the STG, two identical PD neurons and the anterior 104 burster (AB) neuron are strongly electrically coupled and form the pacemaker group. Unless 105 specified otherwise, the PD to LP synapse in this study refers to the combined synaptic current 106 from the pacemaker group to the LP neuron. As expected for a graded synapse, the amplitude 107 of postsynaptic current increased as the presynaptic step voltage increased ( Figure 1B and C). 108
The current-voltage relationship of each synapse was fit with the sigmoidal curve given by 109 equation (1), which is described by three parameters: Imax (synaptic amplitude), Vmid (half-110 activation voltage) and Vc (slope factor at Vmid). A more positive Vmid indicates a higher 111 threshold for activation and larger Vc means a shallower activation curve ( Figure 1D ). For each 112 synapse-peptide pair, we examined how Imax, Vmid and Vc were changed by the peptides (Figure  113 2). 114
For the LP to PD synapse, both CCAP and Proc significantly increased Imax, shifted Vmid to 115 more negative potentials, and reduced Vc across concentrations ( Figure 2A ). In contrast, for the 116 PD to LP synapse, CCAP only increased Imax, but did not affect Vmid or Vc, while Proc only 117
decreased Vc, but did not affect Imax or Vmid (Figure 2A ). 118
Notably, the same peptide differentially modulated different synapses. For example, 119 CCAP changed Imax, Vmid, and Vc at the LP to PD synapse, but only Imax at the PD to LP synapse. In 120 addition, different peptides had different effects on the same synapse. For example, CCAP 121 changed only Imax at the PD to LP synapse, while Proc changed Vc. Overall, both CCAP and Proc 122 strengthened both synapses, although the manner of modulation depended on the synapse 123 and the modulator. 124
We used the data shown in Figure 2 to build predictors for each synapse-peptide pair. 125
The predictor is a surface fit to all synaptic current amplitudes, measured at different 126 presynaptic voltage steps and modulation concentrations ( Figure 3 ), which has a sigmoidal 127 relationship with both the presynaptic voltage and the log of the modulator concentration (fit 128
given by equation (3)). These predictors allow us to estimate the synaptic current at any voltage 129 and modulator concentration by interpolation. The surface fits also allow us to visualize and 130 measure the distinct modulation effects of the two peptides on each synapse and of each 131 peptide on the two synapses. 132
The saturation level of the co-modulatory effect on the synapses is not history 133 dependent
134
Our main hypothesis assumes that the saturation of synaptic co-modulation is not 135 affected by the order of application; that is, one modulator does not gate or prime the effect of 136 the other modulator. Prior to testing our hypothesis, it was therefore important to verify this 137 assumption. To test if the co-modulatory saturation level depended on the prior application of 138 either modulator, we did two separate sets of experiments for each synapse. In each 139 experiment, we saturated the synapse with either Proc or CCAP first, and then with both 140 peptides co-applied. We first examined if co-modulation produced an additional effect above that of the 150 single neuromodulator at 1 µM, the presumed saturation concentration of peptide effects in 151 the STG (Zhao et al., 2011) . In only one of the four cases, co-modulation increased the effect. 152
For the PD to LP synapse, Proc did not completely occlude the effect of adding CCAP, probably 153 because saturating Proc receptors alone does not fully activate the target. In the other three 154 cases, co-application did not produce an additional effect ( Figure 4 ). The fact that complete 155 occlusion was achieved in both synapses by at least one peptide confirms that synapse 156 modulation was maximal when both peptides were applied at 1 µM. 157
Notably, at both synapses, co-modulatory effects were not dependent on the order of 158 application. Synaptic activation curves were not statistically different between experiments in 159 which either CCAP or Proc were applied first ( Figure 4 ). We also verified that the control 160 measurements were not different for each synapse. Therefore, although co-modulation may 161 have additional effects depending on the neuromodulator and the synapse, the saturation level 162 of synaptic co-modulation was not history dependent. 163
Neither CCAP nor Proc modulates short-term synaptic plasticity
164
The pyloric circuit is rhythmically active with a frequency between ~0.5 and 2 Hz 165 (Goaillard et al., 2009 ). Like many synapses in the STG, the LP to PD and PD to LP synapses 166 exhibit short-term synaptic depression (Tseng and Nadim, 2010; Zhao et al., 2011) . In 167 rhythmically active circuits, short-term synaptic plasticity means that the strength of the 168 synapse depends on the period of the rhythm (Manor and Nadim, 2001) . This means that 169 depressing synapses are the stronger the faster the rhythm is, whereas the opposite is true for 170 facilitating synapses. Hence, neuromodulation of short-term synaptic plasticity can play an 171 important role in shaping circuit output and dynamics. 172
At both synapses, we found that neither CCAP, nor Proc, nor co-application of both, 173 significantly changed the level of short-term synaptic depression with a presynaptic voltage 174 step of 40 mV amplitude ( Figure 5 ). This is consistent with a prior study of the effects of Proc on 175 the PD voltage responses to large LP depolarizations (Zhao et al., 2011 ). In the same study, Zhao 176 et al. (2011) described a significant effect on short-term synaptic dynamics when smaller 177 presynaptic voltage-steps were used. However, a detailed analysis of the voltage-dependence 178 of modulatory effects on synaptic plasticity exceeded the scope of our study. 179
Co-modulatory effects on synapses are linearly additive up to saturation 180 After establishing that the saturation level of co-modulation is not history dependent, 181
we used equation (6) to calculate the co-modulation predictions for the synapses. Recall that 182 the individual effects of the two peptides were modeled by the predictors for their dose-183 dependent effects (equation (3) and Figure 3 ). The linear summation rule predicts that the co-184 modulatory effect is the sum of the individual modulatory enhancements due to Proc and CCAP 185 at their respective concentrations (equation (4)), up to saturation. We tested this prediction on 186 both synapses with 18 different modulator combinations (see Methods). 187
We compared our predictions with the experimental results by computing the 188 coefficient of determination (R 2 , evaluating the trend of the data) and normalized root mean 189 squared error (NRMSE, evaluating the deviation of the data from the prediction; see Methods). 190 We report these statistics for each combination individually, and also report the overall R 2 and 191 NRMSE for all combinations. 192
For the LP to PD synapse, our prediction matched the experimental results exceedingly 193
well (examples shown in Figure 6A , all data provided in Figure 6 -source data). The comparison 194 between predicted and measured values showed high prediction accuracy ( Figure 6B , the line y 195 = x indicates a perfect match). For all combinations, we obtained high R 2 and low NRMSE 196 values, indicating that our predictions both captured the trend of the data well and had 197 negligible deviation from the data ( Figure 6C ; see Figure 6 -figure supplement for exact values). 198
The overall values were R 2 = 0.90 and NRMSE = 0.31 for this synapse. We therefore concluded 199 that co-modulation of LP to PD synapse can be predicted from effects of individual peptides 200 using the linear summation rule. 201
We observed simililar accuracy of the linear prediction for the PD to LP synapse 202 (examples shown in Figure 7A , all data provided in Figure 7 -source data). The predictions for 203 the PD to LP synapse also had high R 2 and low NRMSE, with an overall R 2 = 0.73 and NRMSE = 204 0.52 ( Figure 7B and C; see Figure 7 -figure supplement for exact values). These values indicate 205 that co-modulation of the PD to LP synapse was predicted well by the linear summation rule, if 206 not quite as accurately as at the LP to PD synapse. 207
Co-modulatory effects on IMI are not linearly additive
208
Our data indicate that the co-modulatory effects of Proc and CCAP on the synapses 209 were linearly additive, up to saturation. This suggests that the intracellular pathways underlying 210
the Proc and CCAP effects converge in the LP and PD neurons, without additional interactions. If 211 so, it is reasonable to assume that the activation of IMI by Proc and CCAP would also follow the 212 same rule. 213
The protocols that we used to measure the synaptic current from LP to PD also allowed 214 us to estimate the level of IMI in the LP neuron (see Methods and Figure 8A ). We therefore 215
quantified the dose-dependent activation of IMI in the presence of either Proc or CCAP. Both 216 peptides activated IMI starting at nanomolar concentrations and consistently produced larger 217 currents as the concentration increased ( Figure 8B and C). 218
In each experiment, either Proc or CCAP was applied at increasing concentrations up to 219 1µM, and then both peptides were co-applied at 1 µM each. Co-application revealed complete 220 occlusion in both directions and did not show history dependence ( Figure 8C ): The addition of 221 the second peptide did not significantly increase the IMI response, and IMI values were not 222 significantly different between the different orders of application. 223
The dose-dependent curves for the two peptides were used to construct the predictors 224 of the co-modulation effect (equation (5)). From these individual predictors, we calculated the 225 IMI levels expected to be activated by each peptide at any concentration, using linear 226 summation to saturation (equation (7)). As with the synapses, we compared the predicted IMI 227 levels to the actual measurements in 18 different co-modulation combinations. We then 228 calculated the R 2 and NRMSE values for each individual combination and for all combinations 229 together. For these comparisons, IMI was measured at -15 mV. Calculations of the R 2 and 230 NRMSE values with the peak IMI level, derived from the fitted IV curves (equation (2) value of 0.08 and high overall NRMSE value of 0.96 indicate that our linear summation model 238 was a very poor predictor for the co-modulation of IMI and in fact no better than using the mean 239 of the data as a predictor. 240
Interestingly, also in contrast to the fairly consistent R 2 and NRMSE values across 241 different co-modulation combinations for the synapses, these values varied drastically across 242 different combinations for IMI ( Figure 8E middle) . The predictor did very poorly (NRMSE>1) 243
when at least one of the peptide was at a low concentration, but somewhat better (NRMSE 244 closer to 0) when the combined concentrations were high, mostly because the predictor 245 estimated the co-modulation to be at saturation ( Figure 8E ). 246
Despite the poor prediction, our linear model provided some useful information about 247 the dynamics of IMI co-modulation. The measured IMI level was always lower than the 248 prediction, indicating that the co-modulatory effect was sublinear. 249 understanding of neuromodulator actions on their cellular and subcellular targets to explore 265 this topic. Peptide neuromodulation of the pyloric circuit of the STG provides a special 266 opportunity to explore the rules of co-modulation of synaptic and intrinsic ionic currents, and 267
Discussion
to understand their consequences at the circuit level (Daur et al., 2016) . We observed linearly 268 additive co-modulation of synapses, but sub-linearly additive co-modulation of a voltage-gated 269 ionic current in the same neurons. These specific results may be idiosyncratic for the neurons 270
and synapses we studied, as co-modulation of synapses can be nonlinear (Parker, 2000) , and 271 co-modulation of voltage-gated ionic currents could be linearly additive. However, the 272 important lesson from our findings is that converging co-modulation of synapses and ionic 273 currents by the same neurmodulators, or different subcellular targets in general, can follow 274 distinct rules. Given the complex patterns of divergence and convergence of neuromodulators 275 in many systems, this finding likely has broad functional implications. 276
Linearly additive co-modulation of pyloric synapses . We therefore did not necessarily expect 284
co-modulation of synapses to be simply linearly additive. Surprisingly, we observed such 285 linearly additive co-modulation at both synapses. For the LP to PD synapse, CCAP modulation 286 must be presynaptic, as PD neurons do not express CCAP receptors (Garcia et al., 2015) . 287
However, Proc modulation could have both pre-and postsynaptic components. Although Proc 288 receptor expression in these neurons has not been tested because their molecular identity has 289 not been determined in the STG, both neurons show IMI activation in response to Proc 290 application (Swensen and Marder, 2000) . For the PD to LP synapse, both modulators could have 291 pre-and postsynaptic effects. The synaptic input to the LP neuron from the pacemaker (which 292
we measured as the PD to LP synapse) is from both AB and PD neurons. AB expresses CCAP 293 receptors (Garcia et al., 2015) and isolated AB neurons respond to both CCAP and Proc 294 (Swensen and Marder, 2001) . The fact that we measured the synaptic responses of LP while 295 voltage clamping only one of the presynaptic neurons may explain why linear summation less 296 accurately predicts co-modulation compared to the LP to PD synapse ( Figures 6 and 7) . 297
We did not investigate whether neuromodulatory effects occurred pre-or 298 postsynaptically, or both. However, given that we observed linear summation and occlusion, it 299
is likely that modulatory signaling on either side was purely converging, without any nonlinear 300
interactions. Linear co-modulation could also occur through spatial segregation, for example, 301
when one neuromodulator only acts presynaptically, and the other only postsynaptically. Even 302 in a single neuron, modulatory micro-domains can provide non-overlapping, independent 303 activation of identical targets using the same signaling pathways (Lur and Higley, 2015) . 304
However, in the case of spatial segregation, no occlusion should occur, and the saturation level 305 of co-modulation should be the linear sum of the maximum effects achieved by each 306 neuromodulator. 307
Sublinear co-modulation of IMI
308
In contrast to the synapses, we observed nonlinear co-modulation of IMI, which 309 indicated that the signaling pathways targeting IMI were distinct from the pathways targeting 310 the synapses. It was previously suggested that peptides modulate synapses in the STG through 311 their actions on the IMI channel, which might be partially permeable to calcium (Zhao et al., 312 2011; Gray et al., 2017). However, our results indicate that this is unlikely, given that linear co-313 modulation of the synapses and nonlinear co-modulation of IMI occurred in the same 314 experiments. The nonlinearity of IMI co-modulation may have two components: sublinear 315
interactions when at least one modulator is at low concentration, and occlusion when both are 316 at high concentrations ( Figure 8E ). The occlusion effect was also shown in our previous study 317 (Garcia et al., 2015) . 318
In C. borealis, the Proc receptor gene has not been identified, and there appears to be 319 only one CCAP receptor gene (Garcia et al., 2015) . In insects, Proc receptors come from a single 320 gene (Caers et al., 2012) . Different CCAP receptor genes have been found to produce receptors 321 that differ more than 30-fold in their agonist affinities (Li et al., 2011) , but the underlying gene 322
duplication is thought to have occurred only in some insect lineages. However, this does not 323 exclude the possibility of post-translational modifications that could result in receptors with 324 different agonist affinities or differential activation of different signaling pathways (Leclerc et 325 al., 2006; Daaka, 2012) . This opens the possibility that in the STG, peptides activate IMI through 326 receptor subtypes with different affinities. If so, the low-and high-affinity pathways mediated 327 by the same peptides should undergo simple convergence, because the dose-dependent 328 activation of IMI is sigmoidal ( Figure 8C) . Similarly, the low-affinity receptor mediated pathways 329
should also converge without lateral interactions, resulting in occlusion at high concentrations. 330
However, the high-affinity pathway mediated by one peptide might inhibit the low-affinity 331 pathway mediated by the other, possibly by targeting the intracellular calcium concentration or 332 calcium-binding proteins (Gray et al., 2017), thus reducing the IMI level activated by the low-333 affinity pathway. Such an interaction may remain distinct from the linear additive rule of the LP 334 to PD synapses, e.g., if the synaptic neuromodulation pathway is through distinct signaling 335 molecules activated by these receptors. 336
Another possible mechanism is that the CCAP and Proc receptors can form a heteromer 337 complex and display behaviors distinct from either receptor alone (reviewed in Smith and 338
Milligan, 2010). Given the variety of possible mechanisms, a different set of experiments, as 339 well as mathematical modeling, will be required to provide an accurate description of the co-340 modulation rule for IMI. 341
Distinct co-modulation rules may increase flexibility and functionally uncouple the 342 modulation of different targets 343 When different neuromodulators converge onto multiple targets, their actions on the 344 shared targets are inextricably linked. However, modulator effects on different targets can be 345 uncoupled by different co-modulation rules. For example, in the results shown here, 1 nM CCAP 346 and 100 nM Proc produced an additive effect in the LP to PD synapse, but activated much less 347
IMI than 100 nM Proc alone ( Figures 6A, 8C and 8E ). In the pyloric circuit, IMI enhances neuronal 348 excitability of the pacemaker neurons and thereby regulates the pyloric frequency (Hooper and 349 Marder, 1987 co-modulation would ensure that neuronal excitability is not saturated during baseline activity 360 when many peptides may be present at low concentrations. Yet, when any specific peptide 361 neuromodulator is released at a higher concentration, it can produce a distinct circuit output. . Substantial variability has also been described for neuromodulatory 369 components. For example, CCAP receptor mRNA expression varies 3-fold in the LP neuron 370 (n=22 in Garcia et al., 2015) , and CCAP-activated IMI in the LP neuron varies more than 5-fold in 371 amplitude (n=15 in Goaillard et al., 2009 ). There may also be long-term regulatory changes in 372 neuromodulation, perhaps due to seasonal or molt cycle related hormonal changes, which are 373 almost impossible to control for in wild caught animals. In contrast to the data presented here, 374
in a previous study we found that, in LP, CCAP activated a larger IMI than Proc did, and the Proc 375 response was not saturating (Garcia et al., 2015) . In this study, we only tested each co-376 modulation combination on a small number of animals (n=4-6), but the total number of animals 377 we used in this study (n=33) matched the variability of IMI levels seen in the previous studies. 378
The fact that, despite this variability, the linear summation rule accurately predicted co-379 modulation of the synapses indicates that, co-modulation rules appear to be robust across 380 individuals, despite component variability. 381
Bridging levels of co-modulation effects
382
Unraveling the consequences of co-modulation at the circuit level requires examining 383 their interactions at multiple levels. In this study, we took a first step toward identifying the 384 rules of co-modulation at the level of shared targets. However, our study leaves several 385 questions unanswered. 386
First, the signaling pathways resulting in our observed data remain unknown. Second, 387
we bath applied neuromodulators in our study, which was necessary to quantify precise dose-388 dependent effects, but as a number of studies in the STG have shown, fails to address the 389 spatiotemporal dynamics of neuromodulation . Neuromodulators can be 390 released as hormones or as neurotransmitters. In the latter case, spatiotemporal properties of 391 synaptic transmission can be critical in determining circuit output (reviewed in Nusbaum et al., 392 2017). The spatial interactions depend on the architecture of the local circuits, the spatial 393 pattern of neuromodulator release and the peptidase activity. For neurotransmitter 394 modulators, the temporal dynamics is, by necessity, determined by the patterns of activity of 395 the modulatory neurons that release these transmitters. The activity patterns of the 396 modulatory neurons, in turn, is subject to feedback from the activity of the target circuits, 397 thereby producing another potential level of complexity. To probe the spatiotemporal dynamics 398 of co-modulation, combining experimental approaches, such as stimulating neuromodulatory 399 projection neurons, and computational modeling is necessary. 400
Finally, all our experiments were done with voltage-clamp steps in order to characterize 401 the neuromodulatory effects on each target. However, such experiments mask the interactions 402 among circuit components, both those within neurons and those with their synaptic partners. 403
One such example is shown in ( the goal of understanding how neuromodulators interact to shape the circuit output, by 420 quantitatively clarifying the co-modulatory rules at target level. Given co-modulation is a 421 universal and evolutionarily conserved strategy, our results can provide insights and new 422 hypothesis to test at system level. We also provide an initial framework to test similar rules in 423 other circuit components, other neuromodulators and other systems. However, the challenge 424 will remain to translate findings from the level of ionic currents to the effects of co-modulation 425 on actual synaptic function and neuronal excitability, and from there to circuit activity. Even in 426 small circuits with identified neurons, as the pyloric circuit used here, this will require a 427 multipronged approach, combining multiple experimental and computational methods (Nadim 428 and Bucher, 2014 (1) 467
In these fits, we assumed that the postsynaptic current was 0 at Vpre = -70 mV. 468 Proc (Bachem; Torrance, CA and Genscript; Piscataway, NJ) and CCAP (Bachem) were 469 aliquoted in 1 mM stock solutions and stored at -20 °C until use. For each experiment, the 470 aliquots were further diluted to the desired concentrations. The dose-dependent effect of Proc 471 or CCAP on synapses was measured by bath applying each peptide from low to high 472 concentration (1 nM to 1 µM) with a four-minute interval between each concentration. We 473 considered 1 µM to be the saturation concentration of both Proc and CCAP based on previous 474 studies (Zhao et al., 2011) . In addition, 1µM Proc and CCAP were co-applied at the end of each 475 experiment to measure the maximum modulatory effect. 476
To measure short-term synaptic plasticity, we voltage clamped the presynaptic neuron 477 at a holding potential of -60 mV and applied a set of five 500 ms identical depolarizing square 478 pulses, from -60 to -20mV, at 1Hz. We measured the mean current amplitude in the 479 postsynaptic neuron (voltage clamped at -50 mV) in response to each pulse. The level of short-480 term plasticity was quantified as the ratio of the postsynaptic current amplitude elicited by the 481 fifth and first pulses. For the experiments that had two repeated measurements, we averaged 482 the two measurements. 483
Neuromodulatory effects on the voltage-gated ionic current IMI
484
The modulator-activated inward current IMI was measured in the LP neuron in the same 485 experiments in which we measured the LP to PD synaptic current. Because, in these 486 experiments, the LP neuron membrane potential was stepped from -60 to 0 mV for measuring 487 the LP to PD synapse (using the current measured in the postsynaptic PD neuron), the same 488 voltage steps could be used to estimate IMI in the LP neuron (using the voltage-clamp current, 489
ILP, injected in the presynaptic LP neuron). IMI was measured as the difference between ILP 490 measured in the presence of the modulator and ILP measured in control saline ( Figure 8A ) 491 (Golowasch and Marder, 1992) . IMI is a non-inactivating current (Golowasch and Marder, 1992; 492 Gray et al., 2017). To reduce errors due to differences in transient currents, we reported the 493 mean value of the difference current, measured in the second half of each voltage pulse where 494 the currents had reached approximate steady state. The IMI value at -15 mV was measured as 495 the average of the currents elicited at -20 mV and -10 mV step voltage and used for analysis. 496
IMI is a non-inactivating fast voltage-gated inward current whose activation curve is a 497 simple Boltzmann sigmoidal equation (Goaillard et al., 2009 ). The IV curve of IMI can therefore 498 be estimated as 499 max 0 ( )
where gmax is the maximum conductance of IMI, EMI is the reversal potential and I0 is the 501 baseline difference current. 502
The dose-dependent effects of the modulators and the protocols for co-modulation of 503 IMI were the same as those described for the synapses above. 504
Constructing predictors for single neuromodulators 
In these fits, the unit of peptide concentration is M, and the control value was set at C = -10, 511
thus assuming that 10 -10 M concentration had no effect. The enhancement functions for each 512 peptide were defined as the increase produced by the modulator above the control level of the 513 synaptic current at each presynaptic voltage: 514
The resulting enhancement functions served as predictors for the effect of the neuromodulator 516 on the postsynaptic current at any voltage and concentration. 517
In the case of IMI, we fit the dose-dependent effects of Proc and CCAP with the sigmoidal 518 curve 519
where C is the log peptide concentration and Cmid and Cc are, respectively, the half-maximum 521 log concentration and the slope factor. In these fits, the unit of peptide concentration is M, and 522 the control value was set at C = -10, assuming that 10 -10 M concentration had no effect. 523
Predicting and testing co-modulation
524
We compared the predictions of co-modulation effects with the experimental data from 525 co-applications of Proc and CCAP in 18 different combinations of concentrations for both the LP 526
to PD and PD to LP synapses and IMI in the LP neuron. These 18 combinations were divided into 527 four separate groups of experiments, with each group only containing four or five combinations 528 (group information can be found in Figure 6-Figure supplement) . In each group of experiments, 529 each peptide was applied in order from lower to higher concentration. Each combination was 530 bath applied for a four-minute-interval, a value calculated by the superfusion rate, the volume 531 of solution in the line and the size of the petroleum jelly well around the STG. At the end of 532 each experiment, Proc and CCAP were co-applied at 1 µM each to record the maximum 533 modulatory effect in that preparation. 534
The predictions for synapses were calculated by adding up the enhancements produced 535
by each peptide at the respective concentrations (obtained from equation (4)) and the control 536 value ( For each combination, we measured the co-modulated synaptic currents, as described 540 above, at presynaptic voltages from -60 mV to 0 mV, in 10 mV steps. We then compared the 541 measurement with the prediction for those voltages. 542
The co-modulation predictions for IMI were calculated by simply adding up the value of 543
IMI activated by each modulator at its respective concentration on the dose-response curve, 544
limited to the saturation level. 545 ∑ is the total sum of squares. R 2 = 1 means that the prediction 550 perfectly captures the trend of the data. Note, however, that this R 2 is different from the 551
Pearson correlation coefficient where a linear fit to the data is evaluated. In our case, R 2 may be 552 < 0, which simply indicates that the mean of the data avg meas provides a better prediction than 553 the model. 554
The second measure we use is the normalized root mean squared error (NRMSE, 555 normalized to standard deviation), calculated as better prediction than the model. 558
We report both R 2 and NRMSE as recommended by Schunn The prediction values 851 compared with the actual measurements for all data points in the 18 different combinations of 852 co-modulation measurements of the LP to PD synapse. Also shown, for comparison, are the line 853 of perfect prediction (y=x) and overall R 2 values. All data points are provided in Figure 6 -source 854
data. (C) The R 2 and NRMSE values shown for each of the 18 co-modulation combinations of the 855 LP to PD synapse. R 2 =1 and NRMSE=0 indicate perfect predictions, whereas R 2 =0 and NRMSE=1 856 indicate that the prediction was no better than the mean of the data. The bottom panel shows 857 the concentration of Proc, CCAP and total concentration (Proc+CCAP) in each case. Data are 858
shown in order of increasing total concentration. Each combination included 5-6 preparations. 859
Group Proc [M] CCAP [M] R 2 NRMSE
1 10 -9 10 -9 0.98 0.13 2 10 -9 10 -8 0.95 0.22 2 10 -9 10 -7 0.88 0.35 2 10 -9 2x10 -7 0.86 0.37 1 10 -8 10 -9 0.95 0.22 
881
Statistics of the PD to LP synapse co-modulation. Co-applications with the same Group 882 number were performed in the same experiments. 883
Group [Proc] (M) [CCAP] (M) R 2 NRMSE
1 10 -9 10 -9 -0.92 1.38 2 10 -9 10 -8 -62.69 7.98 2 10 -9 10 -7 -4.03 2.24 2 10 -9 2x10 -7 0.08 0.96 1 10 -8 10 -9 -2.27 1.81 3 10 -8 10 -9 -2.78 1.94 1 10 -7 10 -9 -1.82 1.68 4 10 -7 10 -8 -20. 
921
Statistics of the IMI co-modulation. Co-applications with the same Group number were 922 performed in the same experiments. 923
